Clinical Trials
5
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Not Applicable
1 (33.3%)A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma
Not Applicable
Not yet recruiting
- Conditions
- Smoldering Multiple Myeloma (SMM)
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Ciceri Fabio
- Target Recruit Count
- 62
- Registration Number
- NCT07069751
- Locations
- 🇮🇹
Ospedale Giovanni XXIII Policlinico di Bari, Bari, Italy
🇮🇹Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
🇮🇹Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia
Recruiting
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Ciceri Fabio
- Target Recruit Count
- 80
- Registration Number
- NCT06535113
- Locations
- 🇮🇹
GOM Bianchi Melacrino Morelli, Reggio Calabria, Calabria, Italy
🇮🇹IRCCS Ospedale San Raffaele, Milan, Italy
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
Recruiting
- Conditions
- Acute Myeloid Leukemia, in Relapse
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Ciceri Fabio
- Target Recruit Count
- 500
- Registration Number
- NCT05124288
- Locations
- 🇮🇹
IRCCS Ospedale San Raffaele, Milan, Milano, Italy
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
Phase 2
Completed
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy
- Interventions
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Ciceri Fabio
- Target Recruit Count
- 15
- Registration Number
- NCT03961919
- Locations
- 🇮🇹
Ospedale San Raffaele, Milano, Lombardia, Italy
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
Phase 2
Completed
- Conditions
- Graft Vs Host DiseaseTransplant-Related Hematologic MalignancyLeukemia, AcuteFungal InfectionMyelodysplastic Syndromes
- Interventions
- Drug: Conditioning treatment "Thiotepa-Treosulfan-Fludarabine"Procedure: PBSC graftDrug: GvHD prophylaxisDrug: Primary antifungal prophylaxis
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Ciceri Fabio
- Target Recruit Count
- 10
- Registration Number
- NCT03434704
- Locations
- 🇮🇹
Ospedale San Raffaele, Milano, Lombardia, Italy
News
No news found